ARCH, Medicines Co. veterans raise $290 million for in-licensed obesity drugs
After scouring 200 companies’ pipelines, a new biotech firm is launching with one of the most wide-ranging pipelines yet for obesity drug development.
After scouring 200 companies’ pipelines, a new biotech firm is launching with one of the most wide-ranging pipelines yet for obesity drug development.
This JAMA Insights discusses the adverse effects of climate change on mental health and proposes solutions to help mitigate those effects.
Florida has served as a haven for Southern pregnant women with little or no access to abortions. But the Florida Supreme Court upheld a six-week…
Learn more with the AMA and the CDC about the social drivers of health that can influence health inequities in infectious diseases.
Unlike a first trial of PB&TURSO, which led to regulatory approval of this combination therapy in 2022, a second larger and longer multicenter placebo-controlle
Following a medically supervised energy-restricted diet 2 days a week could improve glycemic control in patients with overweight or mild obesity and type 2 diabetes.
More than a million nerve connections are made in the brain in the first few years of life. Babies and young children thrive with responsive…
Background Alzheimer’s disease (AD) is the most frequent cause of dementia. Recent evidence suggests the involvement of peripheral immune cells in the disease, but the…
Findings could offer clues about underlying causes of anorexia
An analysis of NHANES found aspirin’s benefits in primary prevention may hinge on lipoprotein(a) (Lp(a)) levels, halving ASCVD mortality risk with Lp(a) ≥50 mg/dL.
Russ Cook ran side-by-side with Marcus for his final mile at Green Park near Buckingham Palace.